Sezai G. Tunc

Sanliurfa, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Journal: Scientific reports

Published: April 03, 2026

Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

Journal: Medicina (Kaunas, Lithuania)

Published: March 02, 2026

Severe fluoropyrimidine toxicity in a patient with rectal adenocarcinoma with DPYD c.2846A>T heterozygous mutation: A case report.

Severe fluoropyrimidine toxicity in a patient with rectal adenocarcinoma with DPYD c.2846A>T heterozygous mutation: A case report.

Journal: Oncology letters

Published: April 29, 2025

Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Journal: Therapeutic advances in medical oncology

Published: December 10, 2024

Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study.

Concomitant Use of Proton Pump Inhibitors and CDK4/6 Inhibitors in Metastatic Hormone-Positive Breast Cancer: A Real-World Cohort Study.

Journal: Oncology

Published: August 24, 2024

Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Journal: Scientific reports

Published: July 25, 2024

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.

Journal: Oncology

Published: March 24, 2024

Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.

Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Published: November 22, 2023

Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer.

Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer.

Journal: Cureus

Published: May 10, 2023

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.

Journal: European journal of clinical pharmacology

Published: August 04, 2022

Dosimetric comparison of free-breathing versus respiratory motion-managed radiotherapy via four-dimensional computed tomography-based volumetric-modulated arctherapy for lung cancer.

Dosimetric comparison of free-breathing versus respiratory motion-managed radiotherapy via four-dimensional computed tomography-based volumetric-modulated arctherapy for lung cancer.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: July 24, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026